Periods | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 3 Years | All Time |
---|---|---|---|---|---|---|---|
Primex-40 | |||||||
Down Town Hospital Limited |
Particulars |
31-03-2024 |
31-03-2023 |
Shareholder's funds |
|
|
Share capital |
3,00,00,000 |
3,00,00,000 |
Reserves and Surplus |
54,94,36,100 |
49,08,44,200 |
Non-current liabilities |
|
|
Deferred tax Liability (net) |
1,60,74,100 |
1,72,55,500 |
Other long term liabilities |
98,18,600 |
95,39,600 |
Long term provisions |
1,74,00,700 |
1,57,50,000 |
Current liabilities |
|
|
Trade payables |
|
|
Total outstanding dues of creditors other than micro enterprises and small enterprises |
1,41,66,900 |
99,81,800 |
Total outstanding dues of creditors other than micro enterprises and small enterprises |
9,96,81,300 |
8,98,73,300 |
Other current liabilities |
1,69,40,900 |
1,22,58,400 |
Short term provisions |
5,59,300 |
7,17,500 |
Total Equity and Liabilities |
75,40,77,900 |
67,62,20,300 |
Non-current assets |
|
|
Property, plant and equipment |
47,96,19,000 |
25,75,42,200 |
Capital work in progress |
1,18,76,500 |
49,98,500 |
Non-current investments |
1,47,200 |
1,47,200 |
Long term loans and advances |
4,24,01,700 |
8,38,07,000 |
Other non current assets |
49,23,400 |
68,05,800 |
Current assets |
|
|
Inventories Stock in trade |
1,06,69,800 |
93,97,800 |
Inventories Finished goods |
74,77,000 |
66,37,700 |
Trade receivables |
12,47,72,700 |
11,30,36,600 |
Cash and cash equivalents |
6,84,53,800 |
18,25,53,600 |
Short term loans & provisions |
37,36,800 |
1,12,93,900 |
Total Assets |
75,40,77,900 |
67,62,20,300 |
Particulars |
31-03-2024 |
31-03-2023 |
Revenue from operations |
86,15,23,900 |
79,05,24,500 |
Other income |
43,85,500 |
7767600 |
Total Income |
86,59,09,400 |
79,82,92,100 |
Expenses |
|
|
Cost of materials consumed |
6,57,21,500 |
6,14,56,000 |
Purchase of pharmacy items |
9,88,36,800 |
94732400 |
Changes in inventories of stock in trade (Pharmacy) |
-12,72,000 |
-30,07,700 |
Changes in inventories of stock in trade (Others) |
-839300 |
-1031000 |
Employee benefits expenses |
17,68,23,900 |
16,33,23,600 |
Finance cost |
25,000 |
- |
Depreciation |
3,09,79,100 |
3,34,33,000 |
CSR expenditure |
11,57,300 |
8,88,300 |
Other expenses |
40,70,08,400 |
37,18,26,400 |
Total expense |
77,84,40,700 |
72,16,21,000 |
Profit before exceptional items & tax |
8,74,68,700 |
7,66,71,100 |
Prior period adjustments |
-7,89,000 |
45,000 |
Profit Before Tax |
8,82,57,700 |
7,66,26,100 |
Current tax |
2,78,47,200 |
2,35,30,700 |
Deferred tax (net) |
-11,81,400 |
-5,83,800 |
Profit for the year |
6,15,91,900 |
5,36,79,200 |
Earnings per equity share |
|
|
Basic |
21 |
18 |
Diluted |
21 |
18 |
Particulars |
31-03-2024 |
31-03-2023 |
Cash flow from operating activities |
|
|
Profit before taxes |
8,82,57,700 |
7,66,26,100 |
Adjustments for: |
|
|
Depreciation |
3,09,79,100 |
3,34,33,000 |
Finance cost |
25,000 |
- |
Cash flows before working capital changes |
11,92,61,800 |
11,00,59,100 |
Adjustments for: |
|
|
(Increase)/Decrease in Trade receivables |
-1,17,36,100 |
-1,94,85,400 |
(Increase)/Decrease in loans and advances |
4,89,62,400 |
-15,25,000 |
(Increase)/Decrease in Other current assets |
-16,600 |
52,000 |
(Increase)/Decrease in Inventories |
-21,11,300 |
-40,38,700 |
(Increase)/Decrease in Trade payables |
1,39,93,100 |
1,82,28,900 |
(Increase)/Decrease in Other current liabilities |
49,61,500 |
39,31,900 |
(Increase)/Decrease in Provisions |
14,92,500 |
20,65,700 |
Cash flows from operating activities |
17,48,07,300 |
10,92,88,500 |
Income taxes paid (net) |
-2,78,47,200 |
-2,41,50,700 |
Net cash flows from operating activities |
14,69,60,100 |
8,51,37,800 |
Cash flow used in investing activities |
|
|
Proceeds from sale of assets |
67,600 |
1,52,000 |
Purchase of fixed assets |
-25,31,23,500 |
-2,35,42,800 |
Capital work in progress |
-68,78,000 |
-49,98,500 |
Net cash used in investing activities |
-25,99,33,900 |
-2,83,89,300 |
Cash flow from financing activities |
|
|
Loan processing fee paid |
-25,000 |
- |
Dividend paid |
-30,00,000 |
- |
Net cash from financing activities |
-30,25,000 |
- |
Net decrease in cash |
-11,59,98,800 |
5,67,48,500 |
Opening balance of cash and cash equivalents |
18,58,19,400 |
12,90,70,900 |
Closing balance of cash and cash equivalents |
6,98,20,600 |
18,58,19,400 |
Here is a summary of the Cash Flow Statement for the years 2024 and 2023:
Cash Flow from Operating Activities
Profit Before Taxes: The company started with a higher pre-tax profit of Rs. 8,82,57,700 in 2024 compared to Rs. 7,66,26,100 in 2023. This increase indicates improved profitability, which contributes positively to operating cash flows.
Adjustments for Non-Cash and Non-Operating Expenses:
Depreciation: Non-cash depreciation charges amounted to Rs. 3,09,79,100 in 2024 and Rs. 3,34,33,000 in 2023. These amounts were added back to the cash flows, as depreciation is an accounting expense and does not involve an actual outflow of cash.
Finance Cost: A finance cost of Rs. 25,000 was recorded in 2024, though no finance costs were reported in 2023.
After these adjustments, the company reached Rs. 11,92,61,800 in cash flows before changes in working capital for 2024, up from Rs. 11,00,59,100 in 2023.
Changes in Working Capital:
Significant changes in working capital items include an increase in trade payables by Rs. 1,39,93,100 and loans and advances by Rs. 4,89,62,400 in 2024, which collectively increased cash flows.
Other adjustments, such as a decrease in inventories by Rs. 21,11,300 and other current liabilities by Rs. 49,61,500, also had an impact.
These changes contributed to a net operating cash flow of Rs. 17,48,07,300 in 2024, compared to Rs. 10,92,88,500 in 2023, showing improved cash flow generation from core operations.
Income Taxes Paid: The company paid Rs. 2,78,47,200 in taxes in 2024, up slightly from Rs. 2,41,50,700 in 2023. This resulted in a net cash inflow from operating activities of Rs. 14,69,60,100 in 2024, compared to Rs. 8,51,37,800 in 2023, indicating stronger cash inflows from operations.
Cash Flow from Investing Activities
Purchase of Fixed Assets: The company spent Rs. 25,31,23,500 on purchasing fixed assets in 2024, significantly higher than Rs. 2,35,42,800 in 2023. This substantial investment likely represents expansion or upgrades to existing facilities, which can be capital-intensive.
Proceeds from Asset Sales: The company generated Rs. 67,600 from selling assets in 2024, a decrease from Rs. 1,52,000 in 2023.
Capital Work in Progress: An amount of Rs. 68,78,000 was used for capital projects under progress, compared to Rs. 49,98,500 in 2023.
These investing activities resulted in a net cash outflow of Rs. 25,99,33,900 in 2024, significantly higher than the outflow of Rs. 2,83,89,300 in 2023, indicating increased capital expenditure and investments in long-term assets.
Cash Flow from Financing Activities
Dividend Payment and Loan Processing Fees: A dividend payment of Rs. 30,00,000 was made in 2024, alongside a loan processing fee of Rs. 25,000, marking a new outflow category not seen in the previous year.
This resulted in a net cash outflow from financing activities of Rs. 30,25,000 in 2024, with no outflow in 2023.
Net Increase/Decrease in Cash and Cash Equivalents
After considering all operating, investing, and financing activities:
2024: The company had a net decrease in cash of Rs. 11,59,98,800, bringing the closing cash balance to Rs. 6,98,20,600.
2023: There was a net increase in cash of Rs. 5,67,48,500, with a closing cash balance of Rs. 18,58,19,400
Particulars |
2024 |
2023 |
Current ratio |
1.64 |
2.86 |
Debt Equity ratio |
0.3 |
0.3 |
Debt service coverage ratio |
4770.47 |
- |
Return on equity ratio |
0.11 |
0.11 |
Inventory turnover ratio |
10.43 |
12.16 |
Trade recivables turnover ratio |
7.25 |
7.65 |
Trade payables turnover ratio |
1.54 |
1.72 |
Net capital turnover ratio |
10.29 |
3.76 |
Net profit ratio |
7.15 |
6.79 |
Return on capital employed |
14.82 |
14.24 |
Return on Investment |
0.04 |
0.04 |
Here is a summary of the financial and operational metrics for Down Town Hospital Limited for the year 2024 and 2023:
Current Ratio
2024: 1.64 | 2023: 2.86
This ratio reflects the company’s ability to meet short-term obligations with its current assets. A decrease from 2.86 in 2023 to 1.64 in 2024 suggests reduced liquidity, possibly due to increased short-term liabilities or decreased current assets.
Debt-to-Equity Ratio
2024: 0.3 | 2023: 0.3
The consistency in this ratio across both years shows a stable leverage position. A ratio of 0.3 indicates the company uses moderate debt relative to its equity base, suggesting a conservative approach to borrowing.
Debt Service Coverage Ratio (DSCR)
2024: 4770.47 | 2023: Not Applicable
The DSCR for 2024 is exceptionally high, showing a very strong ability to cover debt obligations from its operating income. This significant increase indicates robust cash flow or reduced debt repayments.
Return on Equity (ROE)
2024: 0.11 | 2023: 0.11
ROE measures the profitability relative to shareholders’ equity. An ROE of 0.11 in both years shows consistent profitability, although the low percentage suggests room for improvement in generating returns for shareholders.
Inventory Turnover Ratio
2024: 10.43 | 2023: 12.16
This ratio measures how efficiently inventory is managed. A decrease from 12.16 to 10.43 implies slightly slower inventory movement in 2024, which could indicate reduced demand or increased inventory levels.
Trade Receivables Turnover Ratio
2024: 7.25 | 2023: 7.65
This ratio indicates how quickly the company collects payments from customers. The slight decline in 2024 suggests slower collection, possibly due to extended credit terms or inefficiencies in collection processes.
Trade Payables Turnover Ratio
2024: 1.54 | 2023: 1.72
The decrease here suggests that the company is taking longer to pay its suppliers in 2024. This could be a strategic decision to retain cash longer or an indication of cash flow management issues.
Net Capital Turnover Ratio
2024: 10.29 | 2023: 3.76
A significant increase in this ratio indicates improved efficiency in using working capital to generate sales in 2024. It suggests better management of receivables, payables, and inventory.
Net Profit Ratio
2024: 7.15% | 2023: 6.79%
This increase shows enhanced profitability, with the company retaining a larger portion of sales as net profit in 2024. This improvement could be due to better cost management or higher sales margins.
Return on Capital Employed (ROCE)
2024: 14.82% | 2023: 14.24%
ROCE reflects how efficiently the company uses its capital. The increase in 2024 implies slightly better capital utilization, leading to enhanced returns from its employed capital base.
Return on Investment (ROI)
2024: 0.04 | 2023: 0.04
Consistent ROI shows that investment returns remained stable over the two years, suggesting the company’s investments continue to perform at a steady rate without significant growth.